Dalle, J-H and Lucchini, G. and Balduzzi, A. and Ifversen, M. and Jahnukainen, K. and Macklon, K. T. and Ahler, A. and Jarisch, A. and Ansari, M. and Beohou, E. and Bresters, D. and Corbacioglu, S. and Dalissier, A. and de Heredia Rubio, C. Diaz and Diesch, T. and Gibson, B. and Klingebiel, T. and Lankester, A. and Lawitschka, A. and Moffat, R. and Peters, C. and Poirot, C. and Saenger, N. and Sedlacek, P. and Trigoso, E. and Vettenranta, K. and Wachowiak, J. and Willasch, A. and von Wolff, M. and Yaniv, I. and Yesilipek, A. and Bader, P. (2017) State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) in Baden, Austria, 29-30 September 2015. BONE MARROW TRANSPLANTATION, 52 (7). pp. 1029-1035. ISSN 0268-3369, 1476-5365
Full text not available from this repository. (Request a copy)Abstract
Nowadays, allogeneic haematopoietic stem cell transplantation (allo-HSCT) is a well-established treatment procedure and often the only cure for many patients with malignant and non-malignant diseases. Decrease in short-term complications has substantially contributed to increased survival. Therefore long-term sequelae are reaching the focus of patient care. One of the most important risks of stem cell transplant survivors is infertility. As well as in the field of allo-HSCT also the field of reproductive medicine has achieved substantial advances to offer potential options for fertility preservation in both boys and girls. Access to these procedures as well as their financing differs significantly throughout Europe. As all European children and adolescents should have the same possibility, the Paediatric Diseases Working Party of the European Society for Blood and Marrow Transplantation organised an expert meeting in September 2015. This manuscript describes the recommendations for the diagnosis and pre-emptive procedures that should be offered to all children and adolescents in Europe who have to undergo an allo-HSCT.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | CRYOPRESERVED OVARIAN TISSUE; CANCER; CHILDHOOD; STIMULATION; FAILURE; FEMALES; FEASIBILITY; AUTOGRAFT; PUBERTY; WOMEN; |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Abteilung für Pädiatrische Hämatologie, Onkologie und Stammzelltransplantation |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 14 Dec 2018 13:16 |
| Last Modified: | 25 Feb 2019 13:17 |
| URI: | https://pred.uni-regensburg.de/id/eprint/1612 |
Actions (login required)
 |
View Item |
